Document:

Exhibit 10.22

 Exhibit 10.22 
 Novation Agreement and First Amendment to 
 Amended and Restated Master
Services and Supply Agreement 
 This Agreement is a novation of, and amendment to, the Master Services and Supply Agreement
among LifeScan, Inc. (LifeScan US), Universal Biosensors Pty Ltd (UBS) and Universal Biosensors, Inc. (UBI), dated 29 October 2007 (as subsequently amended and restated, the MSSA) and the associated agreements and
addenda listed in clause 7 (Associated Agreements). By novation, LifeScan Europe, a division of Cilag GmbH International (LIFESCAN Europe) will replace LIFESCAN US as a party to the MSSA and the Associated Agreements. By
amendment, the parties agree to certain terms necessary to give effect to their intention that the MSSA and the Associated Agreements be novated. 
 Background: 
 WHEREAS, LIFESCAN US, UBS and UBI entered
into the MSSA dated 29 October 2007, which was amended by a First Amendment effective 11 December 2008, and was later amended and restated effective 14 May 2009, and LIFESCAN US, UBS and UBI also entered the
Associated Agreements; and 
 WHEREAS, LIFESCAN US assigned and transferred full title and interest in the MSSA, and
certain of the Associated Agreements to LIFESCAN Europe by virtue of an Assignment Agreement effective 1 January 2008 (the Assignment); and 
 WHEREAS, by virtue of the Assignment, LIFESCAN Europe agreed to assume LIFESCAN US’s rights and obligations under the MSSA and those of the Associated Agreements that had been entered
into at the date of the Assignment; and 
 WHEREAS, since 1 January 2008, LIFESCAN US represents that pursuant to
the terms of the Assignment LIFESCAN Europe has reimbursed LIFESCAN US for all costs paid to UBI and UBS by LIFESCAN US under the MSSA and relevant Associated Agreements; and 

  
  

 

					
	Novation Agreement and Amendment	 	Page 1	 	

 WHEREAS, UBS and UBI were not given notice of the Assignment and therefore
performed their rights, duties and obligations under the MSSA and Associated Agreements as though title and interest in those agreements had not been assigned from LIFESCAN US to LIFESCAN Europe; 

WHEREAS, LIFESCAN US and LIFESCAN Europe intended that LIFESCAN US’ title and interest to the MSSA and
Associated Agreements (as existing at the date of the Assignment) be assigned to LIFESCAN EUROPE on 1 January 2008 and that the First Amendment to the MSSA effective 11 December 2008 and the Amended and Restated MSSA effective
14 May 2009 and the Associated Agreements dated 14 May 2009 would be executed by LIFESCAN Europe, but were in fact executed by LIFESCAN US in error. The Parties agree that a Novation shall be implemented to give effect to the
original intent; and 
 WHEREAS, LIFESCAN Europe, LIFESCAN US, UBI and UBS have agreed that,
effective 1 January 2008 all rights in the MSSA and Associated Agreements inuring to the benefit of LIFESCAN US, have inured and shall in the future inure to the benefit of LIFESCAN Europe, and all duties and obligations of
LIFESCAN US under the MSSA and Associated Agreements have been and shall be owed to UBI and or UBS, as the case may be, by LIFESCAN Europe; and 
 WHEREAS, LIFESCAN US, LIFESCAN Europe, UBI, and UBS have agreed that effective 1 January 2008, LIFESCAN US is and shall be released and discharged from all its
rights and obligations under the MSSA and Associated Agreements and all such rights and obligations are assumed by LIFESCAN Europe; and 
 WHEREAS, given UBI and UBS were not on notice of LIFESCAN US’ and LIFESCAN Europe’s intent, UBI and UBS shall have no liability for performing their rights, duties
and obligations under the MSSA and Associated Agreements in the period from 1 January 2008 until the date of this Agreement as though title and interest in the MSSA and Associated Agreements had not been assigned; 

  
  

 

					
	Novation Agreement and Amendment	 	Page 2	 	

 WHEREAS, to give effect to the parties’ intentions, certain amendments to the MSSA are
required, as set forth herein; 
 NOW THERFORE in consideration of the mutual covenants herein contained, the parties for
themselves, their successors and assigns do agree as follows: 
  

	1.	The effective date of this Agreement is 1 January 2008 (the Effective Date). 

 

	2.	LIFESCAN US, LIFESCAN Europe, UBI and UBS agree that this Agreement shall constitute a novation of the obligations of LIFESCAN US under the MSSA
and the Associated Agreements. Accordingly, as of the Effective Date, all of the rights, duties and obligations of LIFESCAN US under the MSSA and Associated Agreements are as of the Effective Date assigned to and assumed by LIFESCAN
Europe. UBI and UBS recognize LIFESCAN Europe as LIFESCAN US’s successor in interest in and to all of LIFESCAN US’s rights, duties and obligations in, to and under the MSSA as of the Effective Date.
UBI and UBS were not on notice of the Assignment and therefore each of LIFESCAN US and LIFESCAN Europe indemnifies and releases UBI and UBS against any claim arising from or in connection with:
(i) UBI and UBS performing their rights, duties and obligations from the Effective Date until the date of this Agreement as though title and interest in the MSSA and the Associated Agreements had not been assigned and novated from
LIFESCAN US to LIFESCAN Europe; and (ii) UBI or UBS following any notices, directions or instructions given by LIFESCAN US prior to the date of this Agreement. LIFESCAN Europe hereby ratifies confirms
and agrees to all notices, directions and instructions given by LIFESCAN US to UBI or UBS in connection with the MSSA or the Quality Agreement up to the date of this Agreement. 

 

	3.	LIFESCAN Europe undertakes to assume and perform the obligations of LIFESCAN US under the MSSA and to be bound by and comply with its terms in every way
as if LIFESCAN Europe were, and had been from inception, a party to the MSSA in lieu of LIFESCAN US. 

  
  

 

					
	Novation Agreement and Amendment	 	Page 3	 	

	4.	Whenever the term “LifeScan” is used in the MSSA it shall mean and refer to LIFESCAN Europe, unless otherwise specifically provided for otherwise.

  

	5.	Any dispute related to this Agreement shall be governed by the provisions of Clause 20 of the MSSA, and the law to be applied in the event of such a dispute shall be as
provided by Clause 26.7 of the MSSA. 

  

	6.	The parties agree to the following amendments to the MSSA. 

  

	a)	The text of Clause 1.1(iii) Bankruptcy is amended by deleting the reference to “U.S. law” and replacing it with “any applicable law”.

  

	b)	The text of Clause 4.2 Composition is deleted in its entirety and replaced with the following: 

“The Joint Steering Committee shall consist of members (Joint Steering Committee Members) from each of UBS and LifeScan. The
Joint Steering Committee Members shall be comprised of senior management from each party (and the initial Joint Steering Committee members are set out in Appendix C); provided however, that LifeScan’s Joint Steering Committee Members can
be comprised of senior management from any of its Affiliates. Each party may change their nominated Joint Steering Committee Member by written notice to the other party. Unless otherwise agreed, the Joint Steering Committee will meet at least
monthly, until the first regulatory filing for the Initial Product is made. Additionally, the Joint Steering Committee shall convene on a quarterly basis, to review and approve work plans and progress under this Agreement and the Development
Agreement. Additionally, the Joint Steering Committee shall be available on a more frequent basis to address key issues that may arise. All meetings of the joint Steering Committee may be by teleconference, videoconference or any other means of
communication agreed to by the parties. 
  

	c)	The first sentence of Clause 11.3(a) is amended by including “and its Affiliates” after the reference to LifeScan in the first line. 

  
  

 

					
	Novation Agreement and Amendment	 	Page 4	 	

	7.	Without prejudice to the provisions of this Agreement and for the sake of clarity, the parties agree that, in addition to the MSSA itself, the following addenda and
related agreements are also novated as provided herein, with LIFESCAN Europe assuming all of the rights, responsibilities and obligations of LIFESCAN US under these addenda and agreements with effect from the Effective Date:

  

	 	a)	Quality Agreement 

  

	 	b)	First Product Addendum 

  

	 	c)	First Services Addendum 

  

	 	d)	Second Services Addendum 

  

	 	e)	Third Services Addendum 

  

	 	f)	Fourth Services Addendum 

  

	 	g)	Manufacturing Initiation Payment Addendum 

 (individually an Associated Agreement and collectively the Associated Agreements) 
  

	8.	This Agreement shall inure to the benefit of and be binding upon the parties hereto and their successors and assigns. 

 

	9.	The parties hereto agree that they will take those actions reasonably necessary to carry out the matters contemplated by this Agreement or any of its provisions.

  

	10.	LIFESCAN US, LIFESCAN Europe, UBI and UBS consent to all of the provisions of this Agreement. 

This Novation Agreement and Amendment may be executed in one or more counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same instrument. Facsimile copies of this Novation Agreement and Amendment shall be enforceable as originals. 
 The parties agree that all other provisions of the MSSA remain unchanged and effective. 

  
  

 

					
	Novation Agreement and Amendment	 	Page 5	 	

 IN WITNESS WHEREOF, the parties have caused this Novation Agreement and First Amendment to
the Amended and Restated Master Services and Supply Agreement to be executed by their duly authorized representatives. 
  

									
	 LifeScan Europe division of Cilag
 GmbH International
	 		 	
					
	By:	  	 /s/ Heinz Schmid
	 		 	By:	 	 /s/ Christian Cuzick

	Name:	  	 Heinz Schmid
	 		 	Name:	 	 Christian Cuzick

	Title:	  	 General Manager
	 		 	Title:	 	 Finance Director

	Date:	  	 September 19, 2011
	 		 	Date:	 	 September 27, 2011

  

									
	Universal Biosensors, Inc.	 		 	LifeScan, Inc.
					
	By:	  	 /s/ Paul Wright
	 		 	By:	 	 /s/ Eduardo A. Baéz

	Name:	  	 Paul Wright
	 		 	Name:	 	 Eduardo A. Baéz

	Title:	  	 CEO
	 		 	Title:	 	 VP Franchise Operations Development

	Date:	  	 October 11, 2011
	 		 	Date:	 	 October 6, 2011

  

			
	Universal Biosensors Pty Ltd
		
	By: 	 	 /s/ Salesh Balak

	Name:	 	 Salesh Balak

	Title:	 	 Director

	Date:	 	 October 11, 2011

  
  

 

					
	Novation Agreement and Amendment	 	Page 6Exhibit 10.23

 Exhibit 10.23 
 SECOND AMENDMENT TO AMENDED AND 
 RESTATED MASTER SERVICES AND SUPPLY
AGREEMENT 
 This agreement is effective as of the date it is executed by all parties and amends the Amended and Restated
Master Services and Supply Agreement (the “Agreement”) between Universal Biosensors Pty. Ltd. and Universal Biosensors, Inc. on the one hand and Cilag GmbH International on the other as follows. 

 

	 	1.	Clause 11.1(b)(ii) is hereby amended to delete the period at the end thereof and substitute therefor ”; plus”. 

 

	 	2.	Clause 11.1(b) is amended to add the following: 

“(iii)(A) for any Covered Products that result or arise from the development of a *[REDACTED] test strip carried out by UBS from Cilag
including under the Development Agreement as amended and restated effective August 19, 2011or from the work carried out by UBS under LifeScan, Inc. purchase orders numbers 285219 0L and 288443 0L (the ”MAP Project”), $*[REDACTED]
per such Covered Product (the “MAP Strips”). 
 For example, if Cilag has sold *[REDACTED] million Covered Products in a
Financial Year and then Covered Products Sold begin to include Map Strip, then subject to Clause 11.1(b)(iii)B, Cilag will pay $*[REDACTED] on each such MAP Strip until the total of all Covered Products Sold, including the MAP Strips, sold by
Cilag is *[REDACTED] million during such Financial Year; and thereafter, during such Financial Year Cilag will pay $*[REDACTED] on each such MAP Strip. 
 (iii)(B) Cilag will pay the $*[REDACTED] on each MAP Strip only until a cumulative total of all MAP Strips Sold reaches *[REDACTED] after which the additional $*[REDACTED] shall no
longer accrue. 
 (iii)(C) The $*[REDACTED] due under (iii)(A) shall not be included in calculation of the Quarterly Service Fee for
purposes of calculating the Lump Sum Service Fee in clause Section 11.3 nor shall it be included in calculation of Quarterly Service Fee for the definition of Fee Conversion Reference Date and such $*[REDACTED] shall be payable by Cilag
regardless of whether Cilag converts the Quarterly Service Fee in accordance with clause 11.3.” 
 The parties agree that, except for the
amendments set forth herein, all other provisions of the Agreement shall remain in force as set forth in the Agreement. 
  

	*	Confidential portion has been omitted and has been filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment.

 IN WITNESS WHEREOF, the parties have caused this Second Amendment to the Amended and
Restated Master Services and Supply Agreement to be executed by their duly authorized representatives. 
 CILAG GMBH INTERNATIONAL 

 

			
	By:	 	   /s/ Heinz Schmid

			
		
	Name:	 	   Heinz Schmid

			
		
	Title:	 	 General Manager

			
		
	Date:	 	 September 19,
2011

			
	By:	 	 /s/ Christian Cuzick

			
		
	Name:	 	  /s/ Christian Cuzick

			
		
	Title:	 	 General Manager

			
		
	Date:	 	 September 27,
2011

 

 

			
	UNIVERSAL BIOSENSORS PTY LTD
		
	By:	 	 /s/ Salesh Balak

			
		
	Name:	 	 Salesh Balak

			
		
	Title:	 	 Director

			
		
	Date:	 	 October 11, 2011

			
	UNIVERSAL BIOSENSORS, INC.
		
	By:	 	 /s/ Paul Wright

			
		
	Name:	 	 Paul Wright

			
		
	Title:	 	 CEO

			
		
	Date:	 	 October 11, 2011

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00195-of-00352.parquet"}]]